Inovio Pharmaceuticals Inc (INO): Inovio up 4% on Orphan Drug tag for INO-...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	52
Posts	4107
Boards Moderated	0
Alias Born	07/03/2005

Opti Mist

Re: None

Wednesday, 07/29/2020 8:25:39 AM

Wednesday, July 29, 2020 8:25:39 AM

Inovio up 4% on Orphan Drug tag for INO-3107
Jul. 29, 2020 8:12 AM ET|About: Inovio Pharmaceuticals... (INO)|By: Douglas W. House, SA News Editor
The FDA designates Inovio Pharmaceuticals' (NASDAQ:INO) INO-3107 an Orphan Drug for the treatment of recurrent respiratory papillomatosis (RRP), a rare disease characterized by the growth of noncancerous tumors, papillomas, in the airways from the nose and mouth into the lungs caused by two types of human papillomavirus (HPV 6 and HPV 11).

A 63-subject Phase 1/2 clinical trial is in process.

Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.

The company says INO-3107 is a DNA-encoded monoclonal antibody that targets HPV 6.

Shares up 3% premarket on modest volume.

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.